Plasma Xanthine Oxidoreductase (XOR) Activity in Cardiovascular Disease Outpatients
Xanthine
DOI:
10.1253/circrep.cr-19-0116
Publication Date:
2020-01-07T22:03:35Z
AUTHORS (18)
ABSTRACT
Background:The mechanisms of the increased plasma xanthine oxidoreductase (XOR) activity in outpatients with cardiovascular disease were unclear.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (30)
CITATIONS (7)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....